-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of April 26, Jiang Rensheng, the actual controller of Zhifei Biology, and Jiang Xisheng, the person acting in concert, reduced their holdings of 16.
411 million shares and 1 million shares, respectively, by 1.
03% and 0.
06%, totaling 1.
09%
.
On that day, Zhifei Biology’s share price was 203 yuan.
The announcement shows that after this reduction, the actual controller Jiang Rensheng's shareholding fell to 802 million shares, and the shareholding ratio fell to 50.
11%
.
According to Capital State statistics, in April two years ago (2019), Jiang Rensheng held 866 million shares, which was 54.
On April 20, Zhifei Bio-Bio released its 2020 annual report and 2021 quarterly report.
In 2020, it achieved operating income of 15.
19 billion yuan, a year-on-year increase of 43.
5%; net profit attributable to the parent company was 3.
30 billion yuan, a year-on-year increase of 39.
5%
.
In the first quarter of 2021, operating income was 3.
